KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Current Deferred Tax Assets (2016 - 2025)

Pfizer (PFE) has disclosed Current Deferred Tax Assets for 16 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Tax Assets rose 19.7% to $4.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 billion, a 19.7% increase, with the full-year FY2025 number at $4.0 billion, up 19.7% from a year prior.
  • Current Deferred Tax Assets was $4.0 billion for Q4 2025 at Pfizer, up from $3.9 billion in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $4.3 billion in Q4 2021 to a low of $2.5 billion in Q4 2022.
  • A 5-year average of $3.5 billion and a median of $3.6 billion in 2022 define the central range for Current Deferred Tax Assets.
  • Peak YoY movement for Current Deferred Tax Assets: tumbled 34.38% in 2022, then soared 53.97% in 2023.
  • Pfizer's Current Deferred Tax Assets stood at $4.3 billion in 2021, then decreased by 16.15% to $3.6 billion in 2022, then increased by 11.21% to $4.0 billion in 2023, then fell by 16.69% to $3.3 billion in 2024, then rose by 19.7% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Current Deferred Tax Assets are $4.0 billion (Q4 2025), $3.9 billion (Q3 2025), and $4.0 billion (Q2 2025).